Final Report of the University Hospital Hradec Králové clinical trial Protocol no. EFC11628

Abstract

Realization of a part of clinical trial called 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-month Safety Extension Period

Keywords

• Type 2 diabetes mellitus
• insulin glargine
• Lantus
• mealtime insulin